Journal article

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

S Rachel Skinner, Anne Szarewski, Barbara Romanowski, Suzanne M Garland, Eduardo Lazcano-Ponce, Jorge Salmeron, M Rowena Del Rosario-Raymundo, Rene HM Verheijen, Swee Chong Quek, Daniel P da Silva, Henry Kitchener, Kah Leng Fong, Celine Bouchard, Deborah M Money, Arunachalam Ilancheran, Margaret E Cruickshank, Myron J Levin, Archana Chatterjee, Jack T Stapleton, Mark Martens Show all

The Lancet | ELSEVIER SCIENCE INC | Published : 2014